SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-190560
Filing Date
2021-06-15
Accepted
2021-06-15 07:16:10
Documents
54
Period of Report
2021-06-15
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d165012d8k.htm   iXBRL 8-K 27073
2 EX-99.1 d165012dex991.htm EX-99.1 44170
3 EX-99.2 d165012dex992.htm EX-99.2 18641
7 GRAPHIC g165012ex99_1s10g1.jpg GRAPHIC 442543
8 GRAPHIC g165012ex99_1s11g1.jpg GRAPHIC 351607
9 GRAPHIC g165012ex99_1s12g1.jpg GRAPHIC 138454
10 GRAPHIC g165012ex99_1s13g1.jpg GRAPHIC 312044
11 GRAPHIC g165012ex99_1s14g1.jpg GRAPHIC 362871
12 GRAPHIC g165012ex99_1s15g1.jpg GRAPHIC 351627
13 GRAPHIC g165012ex99_1s16g1.jpg GRAPHIC 400376
14 GRAPHIC g165012ex99_1s17g1.jpg GRAPHIC 361380
15 GRAPHIC g165012ex99_1s18g1.jpg GRAPHIC 294254
16 GRAPHIC g165012ex99_1s19g1.jpg GRAPHIC 444803
17 GRAPHIC g165012ex99_1s1g1.jpg GRAPHIC 252158
18 GRAPHIC g165012ex99_1s20g1.jpg GRAPHIC 390800
19 GRAPHIC g165012ex99_1s21g1.jpg GRAPHIC 251499
20 GRAPHIC g165012ex99_1s22g1.jpg GRAPHIC 381234
21 GRAPHIC g165012ex99_1s23g1.jpg GRAPHIC 193485
22 GRAPHIC g165012ex99_1s24g1.jpg GRAPHIC 141678
23 GRAPHIC g165012ex99_1s25g1.jpg GRAPHIC 320016
24 GRAPHIC g165012ex99_1s26g1.jpg GRAPHIC 334614
25 GRAPHIC g165012ex99_1s27g1.jpg GRAPHIC 224755
26 GRAPHIC g165012ex99_1s28g1.jpg GRAPHIC 113498
27 GRAPHIC g165012ex99_1s29g1.jpg GRAPHIC 338078
28 GRAPHIC g165012ex99_1s2g1.jpg GRAPHIC 608539
29 GRAPHIC g165012ex99_1s30g1.jpg GRAPHIC 341213
30 GRAPHIC g165012ex99_1s31g1.jpg GRAPHIC 423657
31 GRAPHIC g165012ex99_1s32g1.jpg GRAPHIC 131906
32 GRAPHIC g165012ex99_1s33g1.jpg GRAPHIC 319961
33 GRAPHIC g165012ex99_1s34g1.jpg GRAPHIC 326078
34 GRAPHIC g165012ex99_1s35g1.jpg GRAPHIC 313500
35 GRAPHIC g165012ex99_1s36g1.jpg GRAPHIC 333997
36 GRAPHIC g165012ex99_1s37g1.jpg GRAPHIC 259818
37 GRAPHIC g165012ex99_1s38g1.jpg GRAPHIC 478286
38 GRAPHIC g165012ex99_1s39g1.jpg GRAPHIC 231321
39 GRAPHIC g165012ex99_1s3g1.jpg GRAPHIC 276929
40 GRAPHIC g165012ex99_1s4g1.jpg GRAPHIC 307414
41 GRAPHIC g165012ex99_1s5g1.jpg GRAPHIC 359704
42 GRAPHIC g165012ex99_1s6g1.jpg GRAPHIC 361823
43 GRAPHIC g165012ex99_1s7g1.jpg GRAPHIC 217453
44 GRAPHIC g165012ex99_1s8g1.jpg GRAPHIC 210297
45 GRAPHIC g165012ex99_1s9g1.jpg GRAPHIC 332656
46 GRAPHIC g165012g0615045600808.jpg GRAPHIC 2791
  Complete submission text file 0001193125-21-190560.txt   17102573

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA clsd-20210615.xsd EX-101.SCH 3093
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE clsd-20210615_lab.xml EX-101.LAB 18887
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clsd-20210615_pre.xml EX-101.PRE 11875
47 EXTRACTED XBRL INSTANCE DOCUMENT d165012d8k_htm.xml XML 3483
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 211016877
SIC: 2834 Pharmaceutical Preparations